03 Oct Valproate-containing Medicines – Potential Risk of Neurodevelopmental Disorders in Offspring of Fathers Treated With Valproate in the Three Months Prior to Conception
The document is a Dear Healthcare Professional (DHCP) letter informing healthcare professionals about the risk of neurodevelopment disorders in children born to fathers exposed valproate valproate-containing medicines three months before conception....